Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05873842

TRAns-Femoral Access Intravascular Lithotripsy Comparison With PTA in TAVI

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Rede Optimus Hospitalar SA · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the effectiveness and the safety of femoral-iliac IVL versus balloon only PTA for successful deployment of transfemoral transcatheter aortic valve prosthesis.

Detailed description

Trans-femoral (TF) access has been identified as the best vascular approach for trans-catheter aortic valve implantation (TAVI) in the most recent European Guidelines for the treatment of valvular heart disease. Nevertheless, the TF approach is not possible in a substantial number of TAVI candidates, mainly due to the presence of important peripheral arterial disease (PAD) that is perceived as a contraindication. The presence of PAD limiting TF-TAVI feasibility has always remained a challenging scenario. The concept of preparing TF access through balloon dilatation in case of PAD had been developed and, in this context, percutaneous transluminal angioplasty (PTA) with plain-balloon has been investigated, although available literature is scarce. Intra-vascular lithotripsy (IVL) was proved effective and safe to treat calcified peripheral arteries and such new technology bares the potential for being applied in TF TAVI in patients with concomitant PAD. The rationale is that the Shockwave IVL balloon inflated at low pressure modifies the vessel rigidity with creation of multiple longitudinal and transversal cracks in the calcium present within the vessel wall. Thus, the improved vessel compliance facilitates the successful passage of the valve delivery system resulting in higher rates of procedural success and lower risk for crossover to surgery, vessel injury and major complications.

Conditions

Interventions

TypeNameDescription
DEVICETrans-femoral TAVITrans-femoral TAVI (Trans-catheter Aortic Valve Implantation) with calcified ilio-femoral arteries via PTA (Percutaneous transluminal angioplasty ) or IVL (Intra-vascular Lithotripsy)

Timeline

Start date
2024-07-22
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2023-05-24
Last updated
2025-05-16

Locations

5 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05873842. Inclusion in this directory is not an endorsement.